Cargando…

Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study

BACKGROUND: To study the impact of valvular heart disease (VHD) on hip replacement, particularly the clinical impactions of aortic stenosis before total/partial hip arthroplasty. METHODS: This was a retrospective cohort study. Data on patients who had undergone hip replacement from 2005 to 2014 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Qiang, Wang, Jian, Lian, Yun, Yang, Qinfeng, Zhao, Mingchen, Zhang, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501620/
https://www.ncbi.nlm.nih.gov/pubmed/34627205
http://dx.doi.org/10.1186/s12891-021-04738-z
_version_ 1784580722356387840
author Lian, Qiang
Wang, Jian
Lian, Yun
Yang, Qinfeng
Zhao, Mingchen
Zhang, Yang
author_facet Lian, Qiang
Wang, Jian
Lian, Yun
Yang, Qinfeng
Zhao, Mingchen
Zhang, Yang
author_sort Lian, Qiang
collection PubMed
description BACKGROUND: To study the impact of valvular heart disease (VHD) on hip replacement, particularly the clinical impactions of aortic stenosis before total/partial hip arthroplasty. METHODS: This was a retrospective cohort study. Data on patients who had undergone hip replacement from 2005 to 2014 were extracted from the NIS database. Independent t test and chi-square test were used to analyze the essential characteristics of patients. Multivariate regression was used to estimate the correlation among demographics, comorbidities, complications, hospitalization costs, and time. RESULTS: VHD accounted for 5.56% and AS accounted for 0.03% of the patients before hip replacement surgeries. Patients with VHD before hip replacement are related to the following characteristics: female patients (odds ratio [OR] = 1.15 [1.12–1.18]), elective admission (OR = 0.78 [0.76–0.80]), Charlson Comorbidity Index ≥3 (OR = 1.06 [1.03–1.08]), large-volume hospitals (OR = 1.13 [1.1–1.2]), teaching hospitals (OR = 5 4.4 [2.9–6.7]), and hospital location in urban areas (OR = 1.22 [1.2–1.3]). In addition, VHD is a risk factor for mortality and some acute postoperative medical complications, such as acute cardiac event (OR = 2.96 [2.87–3.04]), acute pulmonary edema (OR = 1.13 [1.06–1.21]), acute cerebrovascular event (OR = 1.22 [1.16–1.74]), and acute renal failure (OR = 1.22 [1.17–1.27]). It also has an impact on DVT/PE (OR = 0.89 [0.8–0.99]). Patients with AS before hip replacement have basic demographic characteristics like those of hip replacement patients with valvular disease. Patients with AS are older than those without AS before surgery (OR = 3.28 [2.27–4.75) and are related to the following characteristics: female patients (OR = 1.92 [1.32–2.8]) and elective admission (OR = 0.51 [0.36–0.75]). The perioperative period is limited to acute postoperative complications, such as acute cardiac events (OR = 2.50 [1.76–3.53]) and acute hepatic failure (OR = 7.69 [1.8–32.89]). Both valvular diseases and AS are associated with a higher mortality rate and hospitalization cost. CONCLUSION: VHD independently predicted mortality rate and surgical and medical complications after total/partial hip arthroplasty. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-021-04738-z.
format Online
Article
Text
id pubmed-8501620
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85016202021-10-20 Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study Lian, Qiang Wang, Jian Lian, Yun Yang, Qinfeng Zhao, Mingchen Zhang, Yang BMC Musculoskelet Disord Research BACKGROUND: To study the impact of valvular heart disease (VHD) on hip replacement, particularly the clinical impactions of aortic stenosis before total/partial hip arthroplasty. METHODS: This was a retrospective cohort study. Data on patients who had undergone hip replacement from 2005 to 2014 were extracted from the NIS database. Independent t test and chi-square test were used to analyze the essential characteristics of patients. Multivariate regression was used to estimate the correlation among demographics, comorbidities, complications, hospitalization costs, and time. RESULTS: VHD accounted for 5.56% and AS accounted for 0.03% of the patients before hip replacement surgeries. Patients with VHD before hip replacement are related to the following characteristics: female patients (odds ratio [OR] = 1.15 [1.12–1.18]), elective admission (OR = 0.78 [0.76–0.80]), Charlson Comorbidity Index ≥3 (OR = 1.06 [1.03–1.08]), large-volume hospitals (OR = 1.13 [1.1–1.2]), teaching hospitals (OR = 5 4.4 [2.9–6.7]), and hospital location in urban areas (OR = 1.22 [1.2–1.3]). In addition, VHD is a risk factor for mortality and some acute postoperative medical complications, such as acute cardiac event (OR = 2.96 [2.87–3.04]), acute pulmonary edema (OR = 1.13 [1.06–1.21]), acute cerebrovascular event (OR = 1.22 [1.16–1.74]), and acute renal failure (OR = 1.22 [1.17–1.27]). It also has an impact on DVT/PE (OR = 0.89 [0.8–0.99]). Patients with AS before hip replacement have basic demographic characteristics like those of hip replacement patients with valvular disease. Patients with AS are older than those without AS before surgery (OR = 3.28 [2.27–4.75) and are related to the following characteristics: female patients (OR = 1.92 [1.32–2.8]) and elective admission (OR = 0.51 [0.36–0.75]). The perioperative period is limited to acute postoperative complications, such as acute cardiac events (OR = 2.50 [1.76–3.53]) and acute hepatic failure (OR = 7.69 [1.8–32.89]). Both valvular diseases and AS are associated with a higher mortality rate and hospitalization cost. CONCLUSION: VHD independently predicted mortality rate and surgical and medical complications after total/partial hip arthroplasty. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-021-04738-z. BioMed Central 2021-10-09 /pmc/articles/PMC8501620/ /pubmed/34627205 http://dx.doi.org/10.1186/s12891-021-04738-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lian, Qiang
Wang, Jian
Lian, Yun
Yang, Qinfeng
Zhao, Mingchen
Zhang, Yang
Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
title Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
title_full Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
title_fullStr Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
title_full_unstemmed Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
title_short Impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
title_sort impact of valvular heart disease on hip replacement: a retrospective nationwide inpatient sample database study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501620/
https://www.ncbi.nlm.nih.gov/pubmed/34627205
http://dx.doi.org/10.1186/s12891-021-04738-z
work_keys_str_mv AT lianqiang impactofvalvularheartdiseaseonhipreplacementaretrospectivenationwideinpatientsampledatabasestudy
AT wangjian impactofvalvularheartdiseaseonhipreplacementaretrospectivenationwideinpatientsampledatabasestudy
AT lianyun impactofvalvularheartdiseaseonhipreplacementaretrospectivenationwideinpatientsampledatabasestudy
AT yangqinfeng impactofvalvularheartdiseaseonhipreplacementaretrospectivenationwideinpatientsampledatabasestudy
AT zhaomingchen impactofvalvularheartdiseaseonhipreplacementaretrospectivenationwideinpatientsampledatabasestudy
AT zhangyang impactofvalvularheartdiseaseonhipreplacementaretrospectivenationwideinpatientsampledatabasestudy